ArticleSpine deformity2026
Mental health disorders do not seem to impact short-term perioperative recovery in adolescent idiopathic scoliosis patients undergoing posterior spinal fusion.
Article in Spine deformity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study investigates how MHD affects perioperative outcome metrics in adolescent idiopathic scoliosis (AIS) patients undergoing posterior spinal fusion (PSF).
methods525 AIS patients underwent PSF between 2018 and 2025. 78 patients were in Mental Health Disorder Group (MHD) and 447 were in no Mental Health Disorder group (nMHD) based on ICD-10 codes. MHD subtypes and prescribed psychotropic medications were categorized. Demographic, radiographic, surgical, and clinical data were collected. Maximum VAS Pain Scores and Morphine Consumption Data were analyzed (in Morphine Milligram Equivalence). Anxiolytic medications during hospital stay were recorded. SRS-22 questionnaire comparison was conducted. Wilcoxon rank-sum tests and Chi-square or Fisher's Exact tests were used.
resultsNo difference in demographic and radiographic variables between groups (p > 0.05). EBL, transfusion, anesthesia, and operative time were not significant (p > 0.05). VAS max pain scores for POD0, POD1, and POD3 were similar, but higher on POD2 in MHD group (p = 0.015). No differences between groups in OOB, LOS, narcotic refills, and 90-day complications (p > 0.05). No significant differences in opioid requirements, but an increase in midazolam for MHD (p = 0.008). SRS-22 showed a significant decrease in Mental Health scores in the MHD group (p = 0.026), but no significance in pain, function, self-image, and satisfaction domains.
conclusionPreexisting MHD disorders were not associated with worse short-term perioperative outcomes. Over the long term, SRS-22 scores indicate that both groups achieve similarly favorable outcomes in pain control, satisfaction, function, and self-image. Continued attention to MHD screening and long-term psychosocial follow-up remains essential, as MHD may be underdiagnosed in adolescents and could potentially exert more profound effects beyond the immediate recovery period. Future studies are needed to determine whether clinical outcomes in MHD patients go beyond the study's timeframe.
Indexed as
Identifiers
42637998What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.